课题基金 / 基金详情

项目摘要

项目成果

HOWARD H. BAILEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT The University of Wisconsin Carbone Cancer Center (UWCCC) seeks continued funding for years 44-48 in pursuit of its mission to dramatically reduce the burden of cancer within and beyond its catchment. The UWCCC, which is a matrix center within the University of Wisconsin School of Medicine and Public Health (SMPH), is composed of 198 faculty members from 38 departments and 8 schools of the University of Wisconsin-Madison (UW). Our members pursue cancer care, research and education through 6 scientific programs (Human Cancer Virology, Cancer Genetic and Epigenetic Mechanisms, Tumor Microenvironment, Imaging and Radiation Sciences, Developmental Therapeutics, and Cancer Prevention and Control) supported by 10 Shared Resources. During the period 2012-2016, our members published 3324 cancer relevant manuscripts (with 66% collaborative) and were supported by $63.7M (Direct) peer-reviewed cancer relevant funding and $16.6M (Direct) non peer-reviewed funding (as of December 31, 2016). The UWCCC will accomplish this mission through nurturing a supportive cancer community, reliable infrastructure, and efficient resources. The UWCCC worked to decrease the burden of cancer in our catchment and beyond through prioritized research areas (e.g. innovative therapies and biomarkers, cancer imaging and expanded population-based cancer research), enhanced research platforms (e.g. improved clinical research infrastructure and shared resources), increased efforts to build mission-related philanthropy and expanded local to global partnerships.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Stress keratin 17 and CD4/8 ratio as prognostic markers in HIV-related anogenital squamous cell precancers and cancers (Biospecimens/Biocohort)
  • 批准号:
    10620051
  • 项目类别:
  • 资助金额:
    $23.9万
  • 财政年份:
    2022
  • 负责人:
    HOWARD H. BAILEY
  • 依托单位:
Defining Tumor Microenvironment and Response to Immune Checkpoint Blockade in HIV-related Anogenital Squamous Cell Carcinomas (Immuno/microenvironment)
  • 批准号:
    10620043
  • 项目类别:
  • 资助金额:
    $24.47万
  • 财政年份:
    2022
  • 负责人:
    HOWARD H. BAILEY
  • 依托单位:
Creating An Efficient Clinical Trial Build System via The Clinical Trials Rapid Activation Consortium (CTRAC)
  • 批准号:
    10227524
  • 项目类别:
  • 资助金额:
    $30.02万
  • 财政年份:
    2020
  • 负责人:
    HOWARD H. BAILEY
  • 依托单位:
The MW Cancer Prevention Clinical Trials Network
  • 批准号:
    10252839
  • 项目类别:
  • 资助金额:
    $171.64万
  • 财政年份:
    2020
  • 负责人:
    HOWARD H. BAILEY
  • 依托单位:
海外基金